Pharmaceuticals & Biotechnology Editor | 05/17/2016
Traditionally the pharma industry has lent towards the view of a one-size fits all approach to the application of therapeutics. Now, eyes are set firmly on the notion of personalised medicine – therapeutics which are tailored to a patient’s specific biomarker information. The progression of next generation sequencing and genome technology is allowing for the first tangible personalised therapies to emerge.However, there are still major strides to be made within molecular diagnostics and the sequ...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
SmartLab Exchange Europe
February 25 - 26, 2025
Novotel Amsterdam City, Netherlands
Register Now |
View Agenda |
Learn More
SmartLab Exchange USA 2025
08 - 09 April, 2025
Le Méridien, Fort Lauderdale, Florida, USA
Register Now |
View Agenda |
Learn More